throbber
NOV.
`
`8. 2005‘
`
`4:51PM
`
`ENZO BIOCHEM
`
`CENTRAL FAX CENTE
`
`p_
`vNo_715o
`I
`F#ESP0NSE UNDER 37 0 FR, 51, Z 26
`EXPEDITED PI-?0CED(JRE
`
`Attorney Docket No.: Enz-7(P)IC3)
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`In re Application of:
`
`Jannis Stavrianopoulos et ai.
`
`Serial No.:
`
`Filed:
`
`For:
`
`08/486,070
`
`June 7, 1995
`
`Group Art Unit: 1631
`
`Primary Exam'r: John S. Brusca
`
`NUCLEIC ACIDS FIXED OR IMMOBILIZED. T0 NON-POROUS.
`SOLID SUPPORT, AND SYSTEM, ARRAY AND NON-POROUS
`GLASS OR PLASTIC SOLID SUPPORT COMPRISING SUCH FIXED
`OR IMMOBILIZED NUCLEIC ACIDS
`'
`
`I
`
`Confirmation No.:
`
`CERTIFIOA TE OF FA CSIMILE TRANSMISSION
`
`Commissioner for Patents
`P.O. Box 1460
`Alexandria, VA 2231 3-1450
`
`Sir:
`
`I. hereby certify that the attached correspondence (total of 52 pages
`
`including this sheet) comprising:
`Supplemental Amendment To Applicants‘ November 2,, 2005 '
`Amendment Under 37 C.F.R. §1.116
`Iinciuding Exhibits A, B & C)
`
`was sent to the United States Patent and Trademark Office by telefax to (5712)
`
`273-8300..
`
`‘Deter November 8, 2005
`
`
`
`bmitted, R spectfully
`
`
`onaid C. Fedus, Reg. No. 32,567
`Natalie Bogdanos, Reg. No. 51,480
`Attorneys for Applicants
`Enzo Life Sciences, Inc.
`clo Enzo Biochem, Inc.
`527 Madison Avenue. 9th Floor
`New York, NY 10022-4304
`Telephone I212) 583-0100
`Facsimile (212) 583-0150
`
`Enz-7 IPI I03)
`
`PAGE 1I52 * RCVD III 11i8I20D5 4:50:40 PM {Eastern Standard Time)‘ ASVRIIISPTO-£FXRF«GJ2i ‘ DIIIS:2?33300 ‘ CSID:2125830150 ‘ DURATION (mm-ss)'1I-I2
`
`Page 1 of 52
`
`
`
`
`
`BD EXHIBIT 1024
`
`

`
`NOV.
`
`8. 2005
`
`4:52PM
`
`ENZO BIOCHEM
`
`p_
`NQ7150
`3 N35 UNDER 37 0 FR § 7 7‘
`CENTRALFAXCENTE g
`0 8
`GROUP ART UNIT 7632
`
`2
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`Group Art Unit: 1631
`
`Primary Examiner: John S. Brusca
`
`527 Madison Avenue, 9?“ Floor
`New York, NY 10022-4304
`November 8, 2005
`
`
`
`l l ) l l l l l l
`
`Applicantlsl:
`
`Stavrianopoulos, at al.
`
`Serial No.:
`
`08l486,07O
`
`Filed:
`
`For:
`
`June 7. 1995
`
`NUCLEICTACIDS FIXED 012 IMMOBJLIZED
`TO NON-POROUS soup supeorrr, AND
`
`svsrsm. ARRAY AND NON-POROUS GLASS .)
`on PLASTIC soup SUPPORT compmsme )
`sucu FIXED on lMMOBlLlZED NUCLEIC ACIDS )
`______.____.....___,%__..____)
`
`TVIA FILED BY F5 QSIMILE TRANSMISSIQM
`T0.’ (703) 872-9306
`
`Mail Stop -7 Non—Fee Amendment
`Commissioner fo'r_Patents
`P.O. Box 1.450
`Alexandria, VA 22313-1450
`
`‘
`
`SUPPLEMENTAL AMENDMENT TO APPLICANTS‘ EOVEMBER 2, 2005
`AMENDMENT UNDEB 37 C.F.R. §‘l .116
`
`Dear-Sirs:~
`
`This paper (Supplemental Amendment) follows Applicants‘ November 2,
`2005 Amendment Under 37 C.F.R. §1.116, the latter heving been filed in response
`
`to the Office Action mailed on September 29, 2005 in connection with the above-
`
`identified application. Their November 2, 2005 Amendment Under 37 C.F.R.
`§1.116 was timely filed. This paper (Supplemental Amendment) is also being
`
`timely filed with no extension request or fee being due.
`
`Enz-7lPl(C3l
`
`PAGE 2152 ‘ RCVD AT lll8l2005 4:50:40 PM [Eastern Standard Time] ‘ SVR:USPTO-£FXRF-6127 ‘ DlllS:273330ll ‘ CSlD:212583015ll‘ DURATION (mm~ss)'10-12
`
`Page 2 of 52
`
`

`
`NOV.
`
`3. 2005
`
`4:52pm
`
`ENZO BIOCHEM
`
`NO. 7160
`
`P.3
`
`U.S. Pat. Appl. Ser. No. 08/486,070 (Wed June 7, 1995}
`Stevrianopoulos et al.,
`To Applicants’ November 2, 2005
`Page 2 [Supplemental Amendment
`Amendment Under 37 C.F.R. §1.11 6]
`-- November 8, 2005]
`
`
`
`CERTIFICATE OF TRANSMISSION
`
`
`
`
`I hereby certify that this paper (Supplemental
`Amendment To Applicants‘ November 2. 2005
`Amendment Under 37 O.F.R. E1 .1 16 (along with any
`documents referred to as attached or enclosed) is being
`
`
`facsimile transmitted to the United States Patent and
`Trademarks {Fax.No. 571-2733300) on November 8.
`2005.
`Nov? zoos’
`
`
`Date
`,
`Ronaid C. Fedus
`Reg. No. 32.567
`
`
`
`
`
`
`
`
`
`Amendments to the Specification and a New Abstract Of The Disclosure are
`requested as reflected in Exhibits A and C accompanying this paper.
`
`Remarks begin on page 42 of this paper.
`
`Enz-7(PHC3)
`
`PAGE 352 ‘ RCVD AT 11812005 4:50:40 PM [Eastern standard Time] ' ‘SVR:USPTO-EFXRF-612?’ DNIS2738300‘ CSlD:2125830150 ' DURATION (mm-ss):10-12
`
`Page 3 01°52
`
`

`
`p_
`N0‘ 7160
`ENZO BIOCHEM
`4:52PM
`N0V.A 8. 2005
`Stavrianopoulos et al., U.S. Pat. Appl. Ser. No. 08/486,070 (Filed June 7, 1995)
`Page 3 [Supplemental Amendment To Applicants’ November 2, 2005
`Amendment Under 37 C.F.R. §1.116]
`— November 8, 2005]
`
`4
`
`New Title of the invention:
`
`Please change the title to:
`
`-- SYSTEM, ARRAY AND NON-POROUS SOLID SUPPORT COMPRISIN
`
`FIXED OR IMMOBILIZED NUCLEIC? ACIDS —-
`
`.
`
`Amendmengg so the Specification:
`
`_
`
`Replace page ’1 of the specification with new Page 1 provided as Exhibit A to this
`
`paper.‘ A marked-up version of Page 1 is also provided as Exhibit A.
`
`_
`
`New Abstract Di‘ The Disclosure:
`Replace the former Abstract with the new Abstract Of The Disclosures provided as
`Exhibit C to this paper.
`’
`
`amendments to the Claims: This listing of the claims below will replace all prior
`versions and listing of claims in this application}
`
`Listing of Claims:
`
`Claims 1-3143 (Canceled).
`
`
`
`‘ An identical claim for priority was made in Applicants‘ March 7, 2001
`Amendment Under 37 C.F.R. §1.’l 15 {see page 2 of that paper, copy provided as
`Exhibit B).
`'
`’
`2 No claims are being amended, canceled or added by this paper.
`
`Enz-7(P)(C3)
`
`PAGE 052 ‘ RCVD AT 111812005 4:50:40 Phi [Eastern Standard Time] ‘ SVR:USPTO<EFXRF-612? ‘ DNISQ738300 ' CSID’2‘|25830150 ‘ DURATION (mm-ss)'10 12
`
`Page 4 01°52
`
`

`
`NOV.
`
`8. 2005
`
`4:52PM
`
`ENZO BIOCHEM
`
`((o,7i50
`
`p_
`
`5
`
`Stavrianopoulos et al., U.S. Pat. Appl. Ser. No. 08/486,070 (filed June 7, 1995i
`Page 4 [Supplemental Amendment To Applicants‘ November 2, 2005
`Amendment Under 37 C.F.R. E31 .116]
`—- November 8, 2005]
`
`Claim 3144.
`
`(Previously Presented) A non‘—porous solid support comprising one or
`
`more amine(s), hydroxyllsi or epoxldelsi thereon, wherein at least one single-
`
`stranded nucleic acid is fixed or immobilized in hybridizable form to said non-porous
`
`solid support via said one or more aminelsi, hydroxylisi or epoxidelsi.
`
`Claim 3145.
`
`(Previously Presented) A non-porous solid support comprising one or
`
`more amine(s), hydroxyl(s) or epoxidelsl thereon, wherein at least one double-
`
`stranded nucleic acid is fixed or immobilized to said non-porous solid support via
`
`said one or more amlnelsi, hydroxyl(s) or epoxidelsl, and wherein one nucleic acid
`
`strand of said at least one double-stranded nucleic acid has covalently attached
`
`thereto either:
`
`(i)
`
`(ii)
`
`.a non-radioactive signaling moiety, or
`
`a non~radioactive bridging moiety covalently or non-covalently
`
`attached to a non-radioactive signaling moiety.
`
`(Previously Presented) The non-porous solid support of claims 3144,
`Claim 3146.
`3146, 3287, 3324 or 3325, wherein said non~porous solid support comprises glass
`
`or plastic.
`
`(Previously Presented) The norrporous solid support of claims 3144,
`Claim 3147.
`3143, 3287, 3324 or 3325, wherein said non-porous "solid support comprises a A
`A
`plate or plates, a well or wells, a microtiter well or microtiter wells, a depression or
`
`depressions, a tube or tubes, or a cuvette or cuvettes.
`
`Claims 31488149.
`
`(Canceled).
`
`Claim 3150.
`
`(Previously Presented) The non-porous solid support of claim 3287 or
`
`3325, comprising one or more amines.
`
`Enz-7lPllC3)
`
`PAGE 5l52 “ RCVD AT 11l8l20D5 4:50:40 PM [Eastern Standard Time) ' SVRZUSPTG-EFXRF-612? * DN|S:2?Ii830ll ' CSlD:212583ll15U' DURATION (mmss):lll-12
`
`Page 5 of 52
`
`

`
`NOV. 8.2005
`
`4:52PM
`
`ENZO BIOCHEM
`
`NQ7150
`
`p_
`
`6
`
`Stavrlanopoulos et al., U.S. Pat. Appl. Ser. No. 08/486,070 (Filed June 7, 1995)
`Page 5 (Supplemental Amendment To Applicants‘ November 2, 2005
`Amendment Under 37 C.F.R. §1.1‘l6]
`
`-- November 8, 2005]
`
`Claim 3151.
`
`(Previously Presented) The non-porous solid support of claims 3144,
`
`3145, 3287, 3324 or 3325, wherein said non-porous solid support has been
`
`treated with a surface treatment agent, .a blocking agent, or both.
`
`Claim. 3152.
`
`(Previously Presented) The non-porous solid support of claim 3‘) 51,
`
`wherein said surface treatment agent comprises an amine providing compound, an
`
`epoxy glue or solution, an acid solution, or ammonium acetate.
`
`Claim 3153.
`
`(Previously Presented) The non—porous solid support of claim 31 51,
`
`wherein said blocking agent comprises Denharclt's solution.
`
`Claim 31 54.
`
`(Previously Presented) The non-porous solid support of claims 3144,
`
`3145, 3287, 3324 or 3325, wherein said fixation or immobilization to said non-
`
`porous solid support is covalent.
`
`(Previously Presented) The non-porous solid support of claims 3144.
`Claim 3155.
`3145, 3287, 3324 or 3325, wherein said fixation or immobilization to. said non-
`
`porous solid support is non-covalent.
`
`' Claim 3156. ‘(Canceied).‘
`
`Claim 3157.
`(Previously Presented) The non—porous solid support of claims 3145,
`3287 or 3325, wherein one strand of said at least one double—stranded nucleic acid
`
`is fixed or immobilized to said non—porous solid support and the other strand of said
`
`at least one double—stranded nucleic acid is hybridized to said one strand.
`
`Enz-7{P)(C3i
`
`PAGE 652’RCVD AT l1i8i20D54:50:4l)Pii1 [Eastern standard Tinie] ' SVR:USPTO=EFXRF-512?*DNiS:2738300 ‘ CSlD:2125830i50‘ DURATTON (mm-5S)'10-12
`
`Page 6 of 52
`
`

`
`NOV.
`
`8. 2005
`4:52PM
`ENZO BIOCHEM
`NQ7160
`P‘
`Stavrianopouios et ai., U.S. Pat. Appl. Ser. No. 08/486,070 (Filed June 7, 1995)
`Page 6 [Supplemental Amendment To Applicants‘ November 2, 2005
`Amendment Under 37 C.F.R.
`5.? 1 .1 16]
`-- November 8, 2005}
`
`7
`
`(Previously Presented) The non-porous solid support of claims 3144
`Claim 3158.
`or 3324, wherein said nucleic acid is DNA.
`
`Claim 3159.
`
`(Previously Presented) The non-porous solid support of claims 3145,
`
`3287 or 3325, wherein said nucleic acid is DNA.
`
`(Previously Presented) The non-porous solidsupport of claim 3144,
`Claim 3160.
`wherein said nucleic acid comprises a nucleic acid sequence complementary to a
`nucleic acid sequence of interest sought to be identified, quantified or sequenced.
`
`(Previously Presented) The non-porous solid supportof ciaims:314-5,
`Claim 3161,
`or 3287, wherein one strand of said at least one doubiestranded nucleic acid
`comprises a nucleic acid sequence of interest sought to be identified, quantified or
`
`sequenced.
`
`(Previously Presented) The non-porous solid support of claims, 3144
`I Claim 3162.
`or 3324, wherein said single-stranded nucleic acid is unlabeled. ‘
`
`(Previously Presented) The non-porous solid support of claims 3144,
`Claim 3163.
`3145, 3287, 3324 or 3325, wherein said non-porous solid support is transparent
`
`' ortranslucent.
`
`(Previously Presented) The non-porous solid support of claims 3145
`Claim 3164.
`or 3287, wherein said non-radioactive signaling moiety is quantifiable in or from a
`fluid or solution, said quantity being proportional to the amount or quantity of said
`non—radioactive signaling moiety.
`'
`
`Enz-7(P)(C3)
`
`PAGE7i52*RCil'DAT11i8i
`
`.
`.
`2
`-
`I
`'
`I
`:
`20054 50 40 PM [Eastern Standard Time] SVR.USPTO=EFXRF-6127 DliiS.2738300 ‘ CSlD.2l2533015U ‘ DURATION (mm-ss):10-12
`
`Page 7 of 52
`
`

`
`NOV.
`
`8. 2005
`4:53PM
`ENZO BIOCHEM
`M07160
`P_
`Stavrianopoulos et al., U.S. Pat. App). Ser. No. 08/486,070 (Filed June 7, 1995)
`Page 7 [Supplemental Amendment To Applicants‘ November .2, 2005
`V-
`Amendment Under 37 C.F.R. §'l.116]
`—- November 8. 2005]
`
`8
`
`(Previously Presented) The non-porous solid support of claims 3145
`Claim 3165.
`or 3287, wherein said non-porous solid support is transparent or translucent. and
`said non-radioactive signaling moiety is quantifiable in or from a fluid or solution or
`
`from said non-porous solid support, said quantity being proportional to the _amount
`
`or quantity of said non—ra’dioactive signaling moiety.
`
`(Previously Presented) The non-porous solid support of claims 3145,
`Claim 3166.
`3287- or 3325, wherein ‘said non-radioactive signaling moiety comprises a
`
`chromagen or e chromagenic compound.
`
`(Previously Presented) The non-porous solid support of claims 3145,
`Claim 3167.
`3287 or 3325, wherein a non-radioactive signal from said non-radioactive signaling
`
`moiety is quantifiable or detectable by photometric techniques.
`
`(Previously Presented) The non—porous solid support of claims 3144
`Claim 3168.
`or 3324, comprising more than one single-stranded nucleic acid.
`
`(Previously Presented) The non—porous solid support of claims 3145.
`Claim 3169.
`3287 or 3325, comprising more than one double-stranded nucleic acid.
`
`Claims 3170-3171 (Canceled).
`
`(Previously Presented) A system comprising a non-porous solid
`Claim 3172.
`support which comprises one or more aminelsl, hydroxyiisi or epoxidels) thereon,
`wherein at least one single-stranded nucleic acid is fixed or immobilized thereto in
`hybridizabie form to said non—porous solid support via said one or more aminels),
`
`hydroxylisi or epoxide(s).
`
`Enz—7(P)(C3l
`
`"‘°E 3‘52’“°V° “T1W2°°54=5°¢4° Pi») Eastern Standard Timersvnzusmsrxmlzvomszzmzou*cslo:2125s3o1so*ouriA11ou (mm-ss)'lD-12
`
`Page 8 of 52
`
`

`
`NOV. 8.2005
`4:53PM
`lallzosioclm.-1
`N07l60
`P
`Stavrianopoulos et al., U.S. Pat. Appl. Ser. No. 08/486,070 (Filed June 7, 1995)
`Page 8 "(Supplemental Amendment To Applicants‘ November 2, 2005
`Amendment Under 37 C.F.Fl. §1.1'i6]
`—- November 8, 2006]
`
`9
`
`(Previously Presented) A system comprising a non—porous solid
`Claim 3173.
`support which comprises oneaor more aminelsl, hydroxyllsl or epoxidelsi thereon,
`wherein at least one double-stranded nucleic acid is fixed or immobilized to said
`non-porous solid, support via said one or more amine(s), hydroxylisi or epoxidelsi,
`and wherein one nucleic acid‘ strand of said double’-stranded nucleic acid has
`
`covalently attached thereto either:
`(i)
`a non-radioactive signaling moiety, or
`(ii)
`a‘ no‘n-radioactive"bridging moiety covalently or nomcovalently
`attached to a non~radioactive signaling moiety.
`
`(Previously Presented) The system of claims 3172, 31 73, 3279,
`Claim 3174.
`3280. 3281 or 3282, wherein said non-porous solid support comprises glass or
`
`plastic.
`
`(Previously Presented) The system of claims 3172, 3173, 3.279.
`Claim 3175.
`3280, 3281 or 3282, wherein "said non-porous solid support comprises a plate .or
`plates, at well or wells, at microtlter well or» rnicrotiter wells, a depression or
`depressions, a tube or tubes, or a cuvette or cuvettes.
`
`Claims 3176-3178.
`
`(Canceled).
`
`(Previously Presented) The system of claims 3172. 3173, 3279,
`Claim 3179.
`3280, 3281 or 3282, wherein said non~porous solid support has been treated with
`a surface treatment agent, a blocking agent. Of both-
`
`(Previously Presented) The system of claim 3179, wherein said
`Claim 3180.
`surface treatment agent comprises an amine providing compound, an epoxy glue or
`solution, an acid solution or ammonium acetate.
`
`Enz-7lP)(C3)
`
`.
`.
`.
`.
`.
`a
`-
`.7
`PAGE9l52‘RCVDliTi1l8l20li5:5:
`4 040Pil[EaslemSlandanlTIme] SVR.USPTO-EFXRF~$l27 nms.2z3saou CSlD.2125830150‘DURAii0li (mm-ss):1li-12
`
`Page 9 of 52
`
`

`
`NV.
`0
`
`.
`.
`82005
`4.53PM
`ENZOBIOCHEM
`Name R10
`Stavrlanopoulos et al., U.S. Pat. Appl. Ser. No. 08/486,070 (Filed June 7, 1995)
`Page 9 [Supplemental Amendment To Applicants‘ November 2, 2005
`Amendment Under 37 C.F.R. §1.116l
`-- November 8, 2005]
`
`Claim 3181.
`
`(Previously Presented) The system of claim 3179, wherein said
`
`blocking agent comprises Denhardfs solution.
`
`(Previously Presented) The system of claims 3172, 3173, 3279,
`Claim 3182.
`3280, 3281 or 3282. wherein said fixation or immobilization to said non-porous
`
`solid support is covalent.
`
`(Previousiy.Pr_esented) The system of claims 3172, 3173, 3279,
`Claim 3183.
`3280, 3281 or 3282, wherein said fixation or immobilization to said non-porous
`
`solid "support. is non-covalent.
`
`Claim 3184.
`
`(Canceled).
`
`(Previously Presented) The system of claims 3173, 3281 or 3282,
`Claim 3185.
`wherein one strand of said doublestranded nucleic acid is fixed or immobilized to
`said non-porous solid support and the other nucleic acid strand of said doubie~
`stranded nucleic acid is hybridized to said one strand.
`
`(Previously Presented) The system of claims 3172 or 3280, wherein
`Claim 3186.
`said nucieie acid as DNA.
`
`Claim 3187.
`
`(Previously Presented) The system of claims 3173, 3281 or 3282,
`
`wherein said nucleic acid is DNA.
`
`(Previously Presented) The system of claim 3172, wherein said
`Claim 3188.
`nucleic acid comprises a nucleic acid sequence complementary to a nucleic acid
`sequence of interest sought to be identified, quantified or sequenced.
`
`Enz-'7(P)(C3l
`
`PAGE 105? ’ RCVD AT 1ii8i2U054:5i:40Pir1[Easiem Standard Time] ‘ Si/R:USPTO-EXRF-5l2? ’ DNlSI2?383li0 * CSlD:2125830l50 ’ DURATION (mm~ss):1ii-12
`
`Page 10 01°52
`
`

`
`NOV. 8.2005
`4:53PM
`ENZOBIOCHEM
`NOW,
`P
`Stavrianopoulos et al., U.S. Pat. Appl. Ser. No. 08/486,070 (Filed June 7, 1995)
`Page 10 [Supplemental Amendment To‘ Applicants‘ November 2, 2005
`Amendment Under 37 C.F.R. §1.116l
`-- November 8. 2005]
`
`ll
`
`Claim 31 89.. (Previously Presented) The system of claims 3173 or 3288, wherein
`one strand of said at least one double-stranded nucleic acid comprises a nucleic
`acid sequence of interest sought to be identified, quantified or sequenced.
`
`(Previously Presented) The system of claim 3172, wherein said
`Claim 3190.
`single—stranded nucleic acid is unlabeled.
`
`(Previously Presented) The system of claims 3172, 3173, 3279,
`Claim 3191.
`3280, 3281 or 3282, wherein said non—porous solid support is transparent or
`
`translucent.
`
`(Previously (Presented) The system of claims 3.173 or 3288. wherein
`Claim 3192.
`said non-radioactive signaling moiety is quantifiable in or from a fluid or solution,
`said quantity being proportional to the amount or quantity of said non-radioactive
`
`signaling moiety.
`
`(Previously Presented) The system of claims 3173 or 3288, wherein
`Claim 3193.
`said non-porous solid support is transparent or translucent, and said non—radioactive
`signaling moiety is quantifiable in or from a fluid or solution or from said non-porous
`solid support, said quantityibeiné proportional to the amount or qiuantity of said
`non—radioactive signaling moiety.
`
`(Previously Presented) The system of claims 3173, 3281 or 3282,
`Claim 3194.
`wherein said non—radioactive signaling moiety comprises a chromagen or a
`
`chromagenic compound.
`
`Enz-7lPl(C3l
`
`PAGE 11152‘ RCVD AT l1l8l20D5 4:50:40 Plil [Eastem Standard Time)’ SVRIUSPTO-EFXRF-5127 “ DNlS:27383fl0 ‘CSlD:2125830l50‘ DURATIOH (mmss):1li-12
`
`Page 11 0f52
`
`

`
`NOV. 3.2005
`4:54PM
`ENZO BIOCHEM
`N0 M60
`P
`V Stavrianopoulos et ai., U.S. Pat. Appl. Ser. No. 08/486,070 (Filed June 7, 1995)
`Page 11 [Supplemental Amendment To Applicants’ November 2, 2005
`Amendment Under 37 C.F.R. §1.1‘l6]
`—- November 8, 2006]
`
`i2
`
`Claim 3195.
`
`(Previously Presented) The system of claims 8173. 3281 or 3282,
`
`wherein a non—radioactive signal from said non-radioactive signaling moiety is
`
`quantifiable or detectable by photometric techniques.
`
`Claim 3196.
`
`lPreviously Presented) The system of claim 3172, comprising more
`
`than one single-stranded nucleic acid.
`
`Claim 3197.
`
`(Previously Presented) The system of claims 3173, 3281 or 3282,
`
`comprising more than one double—stranded nucleic acid.
`
`(Previously Presented) An array comprisingvarious single-stranded
`Claim 31 98.
`nucleic acids’ fixed or immobilized in hybridizable form to a non-porous solid
`
`support.
`
`(Previously Presented) An array comprising various double-stranded
`Claim 3199.
`nucleic acids fixed or immobilized to a non—poro_us solid support, wherein at least
`one nucleic acid strand of said various double-stranded nucleic acids comprises at
`least one non-radioactive signaling moiety which is quantifiable or detectable.
`
`(Previously Presented) The array of claims 3198, 3199, 3300, 330') ,
`Claim 3200.
`3326‘or‘3327, wherein said non-porous solid support comprises glassor pl‘ast'ic‘.
`
`(Previously Presented) The array of claims 3198, 3199, 3300, 330.1,
`Claim 3201.
`3326 or 3327, wherein said non-porous solid support comprises a plate or plates, a
`well or wells, as mlcrotiter well or microtiter walls, a depression or depressions, a
`
`tube or tubes, or a cuvette or cuvettes.
`
`Claims 3202-3203.
`
`(Canceled).
`
`Enz~7(P)lC3l
`
`,
`,
`.
`.
`-
`~-
`PliGEm52‘RC
`l/DATiil8l20ll54.50.40Plviliastemsiandardlimei SVR.USPTO-EFXRF-iilli*DlllS.2?383il0*CSlD:2i25830ii0 DURATl0ll(mm-ss):10-12
`
`Page 12 01°52
`
`

`
`NOV.
`
`.
`82005
`
`.
`4.54PM
`
`ENZOBIOCHEM
`N0.7l60
`P.
`, U.S. Pat. Appi. Ser. No. 08/486,070 (Filed June 7, 1995)
`Stavrianopoulos et al.
`Amendment To Applicants‘ November 2, 2005
`Page 12 {Supplemental
`Amendment Under 37 C.F.R. §‘l .1 16]
`-- November 8, 20061
`
`13
`
`(Previously Presented) The array of claims 3198, 3199, 3300, 3301 ,
`Claim 3204.
`3326 3327, comprising one or more amines.
`
`Claim 3205.
`
`(Previously Pres
`
`ented) The array of claims 3198, 3199, 3300, 3301,
`-porous solid support has been treated with a
`
`3326 or 3327, wherein said non
`surface treatment agent. a blocking agent, or both.
`
`_
`
`(Previously Presented) The array of claim 3205, wherein said surface
`Claim 3206.
`treatment agent comprises an amine providing compound, an epoxy glue or
`solution, an acid solution or ammonium‘ acetate.
`
`(Previously Presented) The array of claim 3205, wherein‘ said
`Claim 3207.
`blocking agent comprises Denhardt's solution.
`
`Presented) The array of claims 3198, 3199, 3300, 3301,
`Claim 3208.
`(Previously
`n-porous solid
`3326 or 3327, wherein said fixation or immobilization to said no
`support is covalent.
`
`(Previously Presented) The array of claims 3198, 3199, 3300, 3301,
`Claim 3209.
`33.26 or 3327, wherein said fixation or immobilization to said’ non-porous solid’
`
`support is non-covalent.
`
`Claim 3210.
`
`(Canceled).
`
`Enz-7(P}(C3)
`
`PAGE 13l52 ' RCVD AT 1ll8l20ll54:5il:-10 Pill [Easlem Standard Time] ’ SVR:USPl'0-EFXRF-5l2? “ DlllS:2738300 ’ CSlD:2i25830l50* DURATl0ll (mm-ss):10-12
`
`Page 13 of 52
`
`

`
`NOV.
`
`8.
`
`:
`2005
`454PM
`ENZO BIOCHEM
`N0_716Q
`P. M
`Stavrianopoulos et al., U.S. Pat. Appl. Ser. No. 03/486,070 (Filed June 7. 1995)
`Page 13 [Supplemental Amendment To Applicants‘ November 2, 2005
`Amendment Under 37 C.F.R. §1.‘l 16]
`-- November 8, 2005]
`
`(Previously Presented) The array of claims 3199 or 3301 , wherein
`Claim 3211.
`the first strands of said double—stranded nucleic acids are fixed or immobilized to
`said non-porous solid support and the other nucleic acid strands of said double-
`stranded nucleic acids are hybridized to said first strands.
`
`Claim 3212.
`
`(Previously Presented) The array of claims 3198 or 3300, wherein
`
`said nucleic acids is DNA.
`
`Claim 3213.
`
`(Previously Presented) The array of claims 3199 or 3301, wherein
`
`said nucleic acids is DNA.
`
`(Previously Presented) The array of claims 3198 or 3289, wherein
`Claim 3214.
`said nucleic acids comprise nucleic acid sequences complementary to nucleic acid
`'sequences of interest sought to be identified. quantified or sequenced.
`
`(Previously Presented) The array of claims 3199 or 3290, wherein
`Claim 3215.
`one strand of said double-stranded nucleic acids comprises a nucleic acid sequence
`of interest sought to be identified, quantified or sequenced.
`
`(Previously Presented) The array of claims 3198 or 3300, wherein
`Claim 3216.
`said single—strande‘d nucleic acids’ are unlabeled.
`
`(Previously Presentedi The array of claims 3198. 3199, 3300,3301,
`Claim 3217.
`3326 or 3327, wherein said non-porous solid support is transparent or translucent.
`
`(Previously Presented) The array of claims 3199 or 3290, wherein
`Claim 3218.
`said norwadioactive signaling moiety is quantifiable in or from a fluid or solution,
`said. quantity being proportional to the amountor quantity of said label or labels.
`
`Enz-7lP)l C3)
`
`PAGE 1452‘ RCVD Al‘ 11l3l2U05l:50:i0Plll[Easlem standard lime] * SVRIUSPTO-EFXRF-5i27 ‘ DN|S:2l38300 * CSlD:2l25330l50 ' DURATION (mm-ss)'l0-12
`
`Page 14 of 52
`
`

`
`NOV.
`
`8. 2
`
`005
`'
`
`4 54PM
`:
`
`Stavrlanopoulos et al.,
`Page 14 [Supplemental
`
`P.
`N0. 7160
`ENZO BIOCHEM
`US. Pat. Appl. Ser. No. 08/486,070 (Filed June 7. 1995)
`Amendment To Applicants’ November 2, 2005
`Amendment Under 37 C.F.R. §1.1i6]
`-- November‘ 8, 2005]
`
`)5
`
`(Previously Presented) The array of claims 3199 or 3290, wherein
`Claim 3219.
`said non-poroussolid support is transparent or translucent, and said non-radioactive
`signaling moiety is quantifiable in or from a fluid or solution or from said non—porous
`solid support, said quantity being proportional to the amount or quantity of said
`non-radioactive signaling moiety.
`
`(Previously Presented) The array of claims 3199, 3331, 3326 or
`Claim‘ 3220.
`3327, wherein said non-radioactive signaling moiety comprises a chromagen or a
`
`chromagenlc compound.
`
`(Previously Presented) The array of claims 3199, 3301.. 3326 or
`Claim 3221.
`.3327, wherein a non-radioactive signal from said non-radioactive signaling moiety
`is quantifiable or detectable by photometric techniques.
`
`(Previously Presented) An array comprising various single-stranded
`Claim 3222.
`nucleic acids fixed or immobilized in hybridizable fonn to a non-porous solid support
`
`having wells or depressions.
`
`(Previously Presented) An array comprising various double-stranded
`Claim 3223.
`nucleic acids ilxed or immobiilzedlto a non—porous solid support having’ wells or
`wherein at least one nucleic acid strand of each of said various
`one non-radioactive signaling
`
`depressions,
`double-stranded nucleic acids comprises at least
`moiety which is quantifiable or detectable.
`
`(Previously Presented) The array of claims 3222 or 3223. wherein
`Claim 3224.
`said non—porous solid support comprises glass or plastic.
`
`Enz-7lPl(C3)
`
`PAGE l5l52 ’ RCVD AT 1ll8l2005 4:50:40 PM [Easiem Standard Time] ' SVRIUSPTUEXRF-5l27 “ DlllS:27383fl0 ‘ CSlD:2125830i50 * DURATl0ll (mm-ss)'l0-12
`
`Page 15 of 52
`
`

`
`NOV.
`
`.
`.
`mmo R16
`ENZOBIOCHEM
`4.54PM
`82005
`Stavrianopoulos et al., U.S. Pat. Appl. Ser. No. 08/486,070 (Filed June 7, 1995)
`Page 15 [Supplemental Amendment To Applicants’ November 2, 2005
`Amendment Under 37 C.F.l-‘l. §1.116]
`-- November 8. 2005}
`
`Claims 322543226.
`
`(Canceled).
`
`Claim 3227.
`
`(Previously Presented) The array of claims 3222 or 3223, wherein
`
`said non~porous solid support comprises oneor more amines.
`
`(Previously Presented) The. array of claims 3222 or 3223, wherein
`Claim 3228.
`said non-porous solid support has been treated with a surface treatment agent, a
`
`blocking agent, or both.
`
`(Previously Presented) The array of claim 3228, wherein said surface
`Claim 3229.
`treatment agent comprises an amine providing compound, an epoxy glue or
`
`solution, an acid solution or ammonium acetate.
`
`Claim 3230.
`
`(Previously Presented) The array of claim 3228, wherein said
`
`blocking agent comprises De-nhardt's solution.
`
`(Previously Presented) The array of claims 3222 or 3223. wherein
`Claim 3231.
`said fixation or immobilization to said non-porous solid support is covalent’.
`
`(Previously-Presented) The array of claims 13222 or 3223, wherein
`Claim 3232.
`saidifixation or immobilization to said norrporous solid supporfis non-covalent.
`
`Claim 3233.
`
`(Canceled).
`
`(Previously Presented) The array of claim 3223, wherein the first
`Claim 3234.
`strands of said double—stranded nucleic acids are fixed or immobilized to said non-
`porous solid support and the other nucleic acid strands of said doublestranded
`nucleic acids are hybridized to said first strands.
`
`‘En:-7u=lic3)
`
`PRGE 16152 ‘ RCVD AT 1118/2005 4:50:40 Pill [Eastern Standard Time] ‘ SVRIUSPTO-EXRF-5l27 ” DNlS:2733300 ‘ CSlD:2125830l50’ DURATION (mm-ss)'10-12
`
`Page 16 of52
`
`

`
`NOV».
`
`4 54PM
`;
`
`8.
`
`2005
`
`P.
`NO.7l60
`ENZO BIOCHEM
`, U.S. Pat. Appl. Ser. No. 08/486,070 (Filed June 7. 1995)
`Stavrianopoulos et al.
`Amendment To Applicants’ November 2, 2005
`Page 16 [Supplemental
`Amendment Under 37 C.F.R. §1.116]
`—- November 8, 2005]
`
`(7
`
`Claim 3235.
`
`(Previously Presented) The array of claim 3222, wherein said nucleic
`
`acids are DNA.
`
`Claim 3236.‘ (Previously Presented) The array of claim 3228, wherein said nucleic
`
`acids are DNA.
`
`(Previously Presented) The array of claim 3222, wherein said nucleic
`Claim 3237‘.
`acids comprise a gene sequence or pathogen sequence.
`
`(Previously Presented) The array of claim 3223, wherein one strand
`Claim 3238,
`of said double—stranded nucleic acids comprises a gene sequence or pathogen
`
`sequence.
`
`Claim 3239.
`
`(Canceled).
`
`(Previously Presented) The array of claim 3222, wherein said single-
`Claim 3240’.
`stranded nucleic acids are unlabeled.
`
`(Previously Presented) The array of claim
`Claim 3241.
`slucent.
`’ said non’-porous solid support is transparent or tran
`
`’
`
`’
`
`S 3222 or 3223, wherein
`
`(Previously Presented) The array of claim 3223, wherein said non-
`Claim 3242.
`radioactive signaling moiety is quantifiable in or from a fluid or solution, said
`quantity being proportional to the amount or quantity of said non-radioactive
`signaling moiety.
`
`Enz-7(Pl(C3)
`
`PAGE 175? ‘ RCVD AT 11l8l20D5 4:50:40 Pill [Easlem Standard Time) ‘ SVRZUSPTO-EFXRF-5l27 ’ DMSZ2738300 ' CSlD:2125830l50 ’ DURRTION (mmss)'10»12
`
`Page 17 of 52
`
`

`
`NOV. 8.2005
`4:55PM
`ENZOBIOCHEM
`N017,”
`P
`Stevrianopoulos et al., U.S. Pat. Appl. Ser. No. 08/486,070 (Filed June 7. 1995)
`Page 17 [Supplemental Amendment To Applicants‘ November 2, 2005
`Amendment Under 37 C.F.R. §1.1’l6]
`—— November 8,; 2005]
`
`18
`
`(Previously Presented) The array of claim 3223, wherein said non-
`Claim 3243.
`porous solid support is transparent or translucent, and said non-radioactive
`signaling moiety is quantifiable in or from a fluid or solution or from said non-porous
`solid support, said quantity being proportional. to the amount or quantity of said
`
`non-radioactive signaling moiety.
`
`Claim 3244.
`
`(Previously Presented) The array of claim 3223, wherein said non-
`
`(Previously Presented) The array of claim 3223, wherein a non-
`Claim 3245.
`radioactive signal from said non-radioactive signaling moiety is quantifiable or
`
`detectable by photometric techniques.
`
`(Previously Presented) A non-porous glass or non-porous plastic solid
`Claim 3246.
`support comprising one or more aminels), hydroxyllsl or epoxidelsl thereon,
`wherein at least one single-stranded nucleic acid is fixed or immobilized in
`hybridizable form to said non-porous solid support via said one or more aminels),
`
`hydroxylls) or epoxidels).
`
`(Previously Presented) A non—porous glass or non—porous plastic solid
`Claim 3247.
`support Icomlprisingmone or more aminels), hydroxylls) or epoxidelsl thereon,
`‘
`rein at least one double-stranded nucleic acid is fixed or immobilized to said
`whe
`minelsli
`non—porous glass or non-porous plastic solid support via said one or more a
`_ hydroxyllsl or epoxidels), and wherein one nucleic acid strand of said double-
`stranded nucleic acid has covalently attached thereto either:
`(i)
`a nomradioactlve signaling moiety, or
`(ill
`a non—radioactive bridging moiety covalently or non-covalently
`attached to a non—radioactive signaling moiety.
`
`Enz-7 (PMC3)
`
`PAGE 18l52 ‘ RCVD AT 'lll8l20D5 4:50:40 PM
`
`:
`.
`-
`[Eastern Standard Time] ‘ SVR.USPTO-El‘-XRF-=6l2? ’ DNlS.27333fl0 CSlD:2125830150 ‘DURATION (mm-ss):l0~l2
`
`Page 18 01°52
`
`

`
`EN20 BIOCHEM
`
`N0 M0
`
`P W
`
`NOV.
`
`8. 2005
`
`4:55PM
`
`Stavrianopoulos et al., U.S. Pat. Appl. Ser. No. 08/486,070 (Filed June 7, 1995).
`Page 18 [Supplemental AmendmentATo Applicants’ November 2, 2005
`Amendment Under 37 C.F.R. §1.1i6]
`-- November 8., 2005]
`
`(Previously Presented) The non—porous glass or non-porous plastic
`Claim 3248.
`,7, wherein said non—porous glass or non-porous
`solid support of claims 3246 or 324
`a, well or wells, a microtiter well or
`plastic solid support comprises a plate or plates,
`microtiter wells, a depression or depressions, a tube or tubes, or a cuvette or
`cuvettes.
`
`Claims 3249-3251 .
`
`(Canceled).
`
`(Previously Presented) The non-porous glass or non-porous plastic
`Claim 3252.
`solid support of claims 3246 or 3247, wherein said non—porous glass or non-porous
`plastic solid support has been treated with a surface treatment agent, a blocking
`agent, or both.
`
`(Previously Presented) The non-porous glassor non-DOFOUS Plastic
`Claim 3253.
`claim 3252, wherein said surface treatment agent compri
`solid support of
`$65 an
`on or
`amine providing compound, an epoxy glue or solution, an acid soiutl
`
`ammonium acetate.
`
`(Previously Presented) The non—porous glass or non-porous plastic
`Claim 3254.
`solid support of exam" 3252, wherein‘ said blocking agent comprises Denhardt‘s~
`
`(Previously Presented) The non-porous glass. or nonporous plastic
`Claim 3255.
`3246 or 3247, wherein said fixation or immobilization to
`solid support of claims
`said non-porous glass or non—porous plastic solid support is covalent.
`
`Enz-7lP)(C3)
`
`PAGEl9l52‘RCVDAT11!8l20054:50:40PM
`
`Si
`l
`[E65 em an
`
`(lard
`
`,
`.
`r
`-
`*
`lime] SVR.USPl’0-EfXRFr5l2l DNlS.2i38300 CSlD:2125830150‘DURAT|0N(mm-ss):10-12
`
`Page 19 0f52
`
`

`
`NOV.
`
`.
`.
`32005
`4.55pm
`ENZOBIOCHEM
`N0.7l60
`P.
`Stavrianopoulos et al., U.S. Pat. Appl. Ser. No. 08/486,070 (Filed June 7, 1995)
`Page 19 [Supplemental Amendment To Applicants‘ November 2, 2005
`Amendment'Under 37 C.F.Fl. §i.116l
`-- November 8, 2006]
`
`20
`
`(Previously Presented) The non~porous glass or non-porous plastic
`Cla

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket